Roopal Thakkar

Statistics

Publications

Citations

8.2K

H-Index

Active since

2001

Affiliations

AbbVie (United States)(Current)

University of California San Diego

AbbVie (Germany)

Amsterdam UMC Location University of Amsterdam

Icahn School of Medicine at Mount Sinai

Roopal Thakkar is an author at AbbVie (United States) specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and pharmacotherapy.

Publications per year

2001–2020

Publications

Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

William J. Sandborn, Gert Van Assche, Walter Reinisch et al. · Gastroenterology · 2011 · 1.3K citations

Life Sciences, Clinical Sciences, Immunology +16

Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure

Alexandre Mebazaa, Markku S. Nieminen, Milton Packer et al. · JAMA · 2007 · 987 citations

Medicine, Cardiology, Pharmacotherapy +17

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt et al. · The Lancet · 2017 · 912 citations

Medicine, Internal Medicine, Gastroenterology +3

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

Walter Reinisch, William J. Sandborn, Daniël W. Hommes et al. · Gut · 2011 · 887 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension

David A. Calhoun, Mari Nishizaka, Mohammad A. Zaman et al. · Hypertension · 2002 · 761 citations

Medicine, Cardiology, Endocrinology +13

1–5 of 52